Boston Scientific Recalls AXIOS Stent and Delivery System Due to Deployment Risks
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Boston Scientific is recalling 557 units of the AXIOS Stent and Electrocautery-Enhanced Delivery System due to reports of deployment and expansion failures that may require surgical intervention.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references Worldwide. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevice.
What Happened
Boston Scientific Corporation has initiated a voluntary Class I recall of the AXIOS Stent and Electrocautery-Enhanced Delivery System. The recall was triggered by an increase in reports regarding stent deployment and expansion issues. According to the manufacturer, these malfunctions can lead to procedural complications, including the inability to properly deploy the device's first flange.
Which Products Are Affected
The recall affects 557 units distributed worldwide, including throughout the United States and Puerto Rico. Affected products include:
- Product Name: AXIOS Stent and Electrocautery-Enhanced Delivery System - 20mm x 10mm
- Material Number (UPN): M00553660 / M00553680
- UDI-DI: 8714729951179
- Recall Number: Z-1158-2026
- Lot Numbers: Over 200 specific lots are affected, including (but not limited to) 35961006, 35961007, 35962524, 35967379, 35968520, 36109761, 36217768, 36325560, 36478478, 36603384, 37050321, 37459573, and 37844023.
What You Should Do
This is a firm-initiated voluntary recall. Healthcare facilities and providers in possession of the affected lots should follow the instructions provided by Boston Scientific Corporation. The firm initiated the notification process on December 19, 2025. Facilities should identify any remaining inventory of the specified material and lot numbers to prevent further use during medical procedures.
Why This Matters
Difficulty deploying or expanding the stent typically results in prolonged medical procedures to exchange the device. In the most serious cases, a failure of the first flange to deploy can necessitate additional endoscopic or surgical intervention to remove the stent and close the puncture site, posing a significant health risk to the patient.
Source
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.